Related Experiment Video
Updated: May 8, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Risk factors of progressive community-acquired pneumonia in hospitalized children: a prospective study
Ching-Ying Huang1, Lung Chang1, Ching-Chuan Liu2
1Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan.
Insights
Identifying risk factors for progressive pneumonia in children is crucial for timely treatment. Key indicators include young age, pleural effusion, low hemoglobin, high white blood cell count, tachypnea, and prolonged fever.
Area of Science:
- Pediatric Medicine
- Infectious Diseases
- Critical Care
Background:
- Pneumonia complications pose significant risks for hospitalized children.
- Early identification of progressive pneumonia is essential for effective management.
Purpose of the Study:
- To identify risk factors associated with the development of progressive pneumonia in children.
- To guide early therapeutic interventions for pediatric pneumonia.
Main Methods:
- Prospective study across seven Taiwanese medical centers.
- Enrolled 402 children (6 weeks to 18 years) with community-acquired pneumonia (CAP).
- Compared demographic, clinical, laboratory, and etiological factors between progressive and non-progressive pneumonia cases.
Main Results:
- 14.2% of children developed progressive pneumonia.
- Independent risk factors identified: age < 2 years, pleural effusion, Hb < 10 g/dL, WBC > 17,500/μL, tachypnea, and fever duration > 3 days.
- Streptococcus pneumoniae was the primary pathogen in progressive pneumonia (57.9%).
Conclusions:
- Six clinical factors can predict progressive pneumonia in hospitalized children.
- Children with persistent fever beyond 72 hours require further evaluation.
- Initial antibiotic choice did not influence the progression of pneumococcal pneumonia.
Background:
Complications regarding pneumonia occur in children during hospitalization and treatment. The objective of this study is to identify the risk factors of progressive pneumonia in order to institute early appropriate therapy.
Methods:
This was a prospective study which involved the pediatric departments of seven medical centers in Taiwan. Children aged from 6 weeks to 18 years old, hospitalized with community-acquired pneumonia (CAP) from January 2010 to August 2011, were enrolled. Progressive pneumonia was defined by the deterioration of discharge diagnosis as compared to admission. Demographic, clinical, and laboratory variables, diagnosis, antimicrobial therapy, and pathogens were compared.
Results:
Four hundred and two children were included and 57 (14.2%) had progressive pneumonia. Independent associated factors identified for the development of progressive disease, by multivariate logistic regression analysis, included the following, age < 2 years, pleural effusion as admission diagnosis, Hb < 10 g/dL, WBC count > 17,500/μL, tachypnea, and duration to defervescence > 3 days. Streptococcus pneumoniae was the main etiology for progressive pneumonia (57.9%). There was no difference in choice of initial parenteral antibiotics between groups of progressive and non-progressive pneumococcal pneumonia.
Conclusion:
We found six clinical factors for predicting progressive pneumonia. Further evaluation should be performed in hospitalized pneumonic children with persistent fever not responding to therapy within 72 hours. The initial parenteral antibiotics were not related to the progression of pneumococcal pneumonia.
Related Concept Videos
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pneumonia II: Pathophysiology